SCHEMBL5072092

SCHEMBL5072092

COC(=O)CCc1cc(Br)c(O)c(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.54
ALOX5 P09917 5/20 0.52
PTGS2 P35354 1/20 0.49
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
TNKS2 Q9H2K2 2/20 0.46
MAPT P10636 3/20 0.46
KMT2A Q03164 3/20 0.46
ALDH1A1 P00352 3/20 0.46
MEN1 O00255 2/20 0.46
GAA P10253 2/20 0.46
USP2 O75604 1/20 0.46
ALOX15 P16050 1/20 0.46
ALOX12 P18054 1/20 0.46
HSD17B10 Q99714 1/20 0.46
OR51E2 Q9H255 1/20 0.46
KDM4E B2RXH2 2/20 0.44
PTPN1 P18031 1/20 0.43
PDE4D Q08499 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL490925 0.89 ALOX5 (0.62) ALOX5NFKB1NFKB2RELATNKS2
SCHEMBL3130670 0.89 TRPV1 (0.44) TRPV1ALOX5MAPTKMT2AALDH1A1
SCHEMBL3681959 0.87 ALOX5 (0.55) TRPV1ALOX5PTGS2TNKS2MAPT
SCHEMBL14311297 0.86 ALOX5 (0.56) TRPV1ALOX5PTGS2NFKB1NFKB2
SCHEMBL1525224 0.84 HSP90AB1 (0.54) TRPV1ALOX5PTGS2MAPTKMT2A
SCHEMBL28853057 0.82 TRPV1 (0.54) TRPV1ALOX5NFKB1NFKB2RELA
SCHEMBL3684924 0.82 THRA (0.39) TRPV1ALOX5MAPT
SCHEMBL11213629 0.82 ALOX5 (0.52) ALOX5NFKB1NFKB2RELATNKS2
SCHEMBL3679438 0.82 RPS6KA3 (0.39) TRPV1ALOX5MAPTKMT2AALDH1A1
SCHEMBL16294204 0.80 ALOX5 (0.54) ALOX5MAPTKMT2AMEN1OR51E2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7319163-B2 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders KARO BIO AB (SE) 2008-01-15 US disclosed
US-7005538-B1 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders KARO BIO AB (SE) 2006-02-28 US disclosed
US-20050267206-A1 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders MALM JOHAN 2005-12-01 US disclosed
WO-2001036365-A2 THYROID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CARDIAC AND METABOLIC DISORDERS KARO BIO AB (SE) 2001-05-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050267206-A1 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders TSHR, THRB, THRA TRPV1 331/4885ALOX5 2020/4885PTGS2 2771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.